Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis

Zhang L, Zlotoff DA, Awadalla M, Mahmood SS, Nohria A, Hassan MZ, Thuny F, Zubiri L, Chen CL, Sullivan RJ, Alvi RM, Rokicki A, Murphy SP, Jones-O'Connor M, Heinzerling L, Barac A, Forrestal BJ, Yang EH, Gupta D, Kirchberger M, Shah SP, Rizvi MA, Sahni G, Mandawat A, Mahmoudi M, Ganatra S, Ederhy S, Zatarain-Nicolas E, Groarke JD, Tocchetti CG, Lyon AR, Thavendiranathan P, Cohen JV, Reynolds KL, Fradley MG, Neilan TG (2020)


Publication Type: Journal article

Publication year: 2020

Journal

Book Volume: 141

Pages Range: 2031-2034

Journal Issue: 24

DOI: 10.1161/CIRCULATIONAHA.119.044703

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Zhang, L., Zlotoff, D.A., Awadalla, M., Mahmood, S.S., Nohria, A., Hassan, M.Z.,... Neilan, T.G. (2020). Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis. Circulation, 141(24), 2031-2034. https://doi.org/10.1161/CIRCULATIONAHA.119.044703

MLA:

Zhang, Lili, et al. "Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis." Circulation 141.24 (2020): 2031-2034.

BibTeX: Download